Volume 28 Issue 6
Dec.  2004
Article Contents

Citation:

Application of 99Tcm-MIBI scintimammography to diagnose P-gP of breast cancer

  • Received Date: 2004-07-20
  • The article discuss the advances in 99Tcm-sestamibi scintimammography to diagnose P-gly-coprotein of breast cancer in multidrug resistance. As a kind of noninvasive fuctional test imaging technology, SPECT can be used to diagnose P-glycoprotein expression in breast cancer and can make decision for clinical treatment.
  • 加载中
  • [1] 周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2003.85.
    [2] Galimberti S,Marchetti A,Buttitta F,et al.Multidrug resistance related genes and p53 expression in human NSCLC[J].Anticancer Res,1998,18(4C):2973-2976.
    [3] Trock BJ,Ceonessa F,Clarke R,et al.Multidrug resistance in breast cancer:A Meta-analysis of MDR1/gp-170 expression and its possible fuctional significance[J].J Natl Cancer Inst,1997,89:917-931.
    [4] 王树滨,刘雅洁,隋广杰等.P-糖蛋白在乳腺癌组织中的表达与预后的关系[J].中国肿瘤临床,2001,28(5):325-328.
    [5] Cordobes MD,Starze A,Delmon-Moingeon L,et al.Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells:Corre lation with mdr gene expression[J].J Nucl Med,1996,37:286-289.
    [6] Vecchio SD,Ciarmiello A,Leonardo P,et al.Fractional retention of the technetium-99m-sestamibi as an index of P-glycoprotein rxpres-sion in untreated breast cancer patients[J].J Nucl Med,1997,38(9):1348-1351.
    [7] Kostakoglu L,Elahi N,Kiratli P,et al.Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors[J].J Nucl Med,1997,38(7):1003-1008.
    [8] Nishiyama Y,Kawasaki Y,Yamamoto Y,et al.Technetium-99m-MIBI and thailium-201 scimtigraphy of primary lung cancer[J].J Nucl Med,1997,38(9):1358-1361.
    [9] Chia-Hung K,Shih-Chuan T,Liu TG,et al.P-glycpprotein and multidrug-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammorgraphy findings[J].Cancer Res,2001,15(61):1412-1414.
    [10] Shung-Shung S,Tih-Fang H,Shih-chuan T,et al.Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results[J].Cancer Lett,2000,153(1-2):95-100.
    [11] Del-Vecchio S,Ciarmiello A,Pue L,et al.Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients[J].J Nucl Med,1997,38(9):1348-1351.
    [12] Del-Vecchio S,Ciarmiello A,Potena MI,et al.In Vivo detection of multidrug-resistance (MDR1) phenotype by technetium-99m ses-tamibi scan in untreated breast cancer patients[J].Eur J Nucl Med,1997,24(2):150-159.
    [13] Muriel A,Noreli F,Jean-Marc R,et al.Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer[J].Breast Cancer Res Trea,2000,61(1):13-20.
    [14] Van de Vijver MJ,He YD,vant Veer LJ,et al.A gene-expression signature as a predictor of survival in breast cancer[J].Engl J Med,2002,347(25):1999-2009.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(1127) PDF downloads(2) Cited by()

Related
Proportional views

Application of 99Tcm-MIBI scintimammography to diagnose P-gP of breast cancer

  • Department of Medical Oncology, Jiangyin Hospital, Southeast University, Jiangyin Jiangsu, 214400, China

Abstract: The article discuss the advances in 99Tcm-sestamibi scintimammography to diagnose P-gly-coprotein of breast cancer in multidrug resistance. As a kind of noninvasive fuctional test imaging technology, SPECT can be used to diagnose P-glycoprotein expression in breast cancer and can make decision for clinical treatment.

    HTML

Reference (14)

Catalog

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return